Literature DB >> 26978581

The prevalence, awareness, treatment and control of dyslipidemia among adults in China.

Ling Pan1, Zhenhua Yang1, Yue Wu1, Rui-Xing Yin2, Yunhua Liao3, Jinwei Wang4, Bixia Gao4, Luxia Zhang4.   

Abstract

OBJECTIVES: To analyze the prevalence, awareness, treatment, control and epidemiological characteristics of dyslipidemia in Chinese adults.
METHODS: In this cross-sectional study, we adopted a multi-stage, stratified sampling method to obtain representative samples of the general population aged >18 years from different urban and rural regions in China. All subjects completed a lifestyle and medical history questionnaire and were examined for risk factors. Dyslipidemia was defined according to criteria of the 2007 Chinese Guidelines on Prevention and Treatment of Dyslipidemia in Adults. Continuous variables were compared using variance analysis. Multivariate logistic regression analysis was performed to explore the risk factors of dyslipidemia.
RESULTS: The prevalence of dyslipidemia was 34.0% overall, and 35.1%, and 26.3% in urban and rural areas, respectively. The prevalence of dyslipidemia was significantly higher in men than women (41.9% vs 32.5%; P < 0.001). Rates of awareness, treatment, and control were 31.0%, 19.5%, and 8.9%, respectively. Increasing age (OR = 1.012; 95% CI:1.010, 1.014), male sex (OR = 1.411; 95% CI:1.318, 1.510), obesity (OR = 1.424; 95% CI:1.345, 1.507), cardiovascular disease (OR = 1.343; 95% CI:1.125, 1.603), diabetes (OR = 1.955; 95% CI:1.751, 2.182), hypertension (OR = 1.481; 95% CI:1.391, 1.577) and hyperuricemia (OR = 2.223; 95% CI:2.060, 2.399) were independent risk factors of dyslipidemia.
CONCLUSION: The prevalence of dyslipidemia among Chinese adults was high but awareness, treatment, and control of dyslipidemia were low. Urban high income earners and rural medium income earners show higher prevalence. Low income earners in urban and rural population have the worst awareness treatment, and control rate. There is an increased need for closely monitoring and controlling high risk factors in the populations including postmenopausal women, unhealthy lifestyle peoples and patients with chronic non-communicable diseases.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  China; Dyslipidemia; Epidemiology; Prevalence

Mesh:

Substances:

Year:  2016        PMID: 26978581     DOI: 10.1016/j.atherosclerosis.2016.02.006

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  109 in total

1.  Venous Blood-Based Biomarkers in the China Health and Retirement Longitudinal Study: Rationale, Design, and Results From the 2015 Wave.

Authors:  Xinxin Chen; Eileen Crimmins; Peifeng Perry Hu; Jung Ki Kim; Qinqin Meng; John Strauss; Yafeng Wang; Junxia Zeng; Yuan Zhang; Yaohui Zhao
Journal:  Am J Epidemiol       Date:  2019-11-01       Impact factor: 4.897

Review 2.  Drug Therapy of Dyslipidemia in the Elderly.

Authors:  Srikanth Yandrapalli; Shashvat Gupta; Gabriela Andries; Howard A Cooper; Wilbert S Aronow
Journal:  Drugs Aging       Date:  2019-04       Impact factor: 3.923

3.  The prevalence of multiple non-communicable diseases among middle-aged and elderly people: the Shanghai Changfeng Study.

Authors:  Huandong Lin; Qian Li; Yu Hu; Chouwen Zhu; Hui Ma; Jian Gao; Jiong Wu; Hong Shen; Wenhai Jiang; Naiqing Zhao; Yiqing Yin; Baishen Pan; Johannes Jeekel; Albert Hofman; Xin Gao
Journal:  Eur J Epidemiol       Date:  2016-12-20       Impact factor: 8.082

4.  Combined Effects of Dyslipidemia and High Adiposity on the Estimated Glomerular Filtration Rate in a Middle-Aged Chinese Population.

Authors:  Xichang Wang; Haoyu Wang; Jiashu Li; Xiaotong Gao; Yutong Han; Weiping Teng; Zhongyan Shan; Yaxin Lai
Journal:  Diabetes Metab Syndr Obes       Date:  2021-11-10       Impact factor: 3.168

5.  Evaluation of health-related quality of life in adults with and without dyslipidaemia in rural areas of central China.

Authors:  Hui Wu; Huijun Li; Haibin Li; Yu Ding; Chongjian Wang; Guicheng Zhang; Naijun Tang; Weidong Wu
Journal:  Qual Life Res       Date:  2019-10-26       Impact factor: 4.147

6.  Prevalence of hypertension, diabetes, and dyslipidemia, and their additive effects on myocardial infarction and stroke: a cross-sectional study in Nanjing, China.

Authors:  Shan Lu; Ming-Yang Bao; Shu-Mei Miao; Xin Zhang; Qing-Qing Jia; Shen-Qi Jing; Tao Shan; Xiao-Hong Wu; Yun Liu
Journal:  Ann Transl Med       Date:  2019-09

7.  Associations of long-term exposure to ambient nitrogen dioxide with indicators of diabetes and dyslipidemia in China: A nationwide analysis.

Authors:  Qingli Zhang; Cong Liu; Yafeng Wang; Jinquan Gong; Gewei Wang; Wenzhen Ge; Renjie Chen; Xia Meng; Yaohui Zhao; Haidong Kan
Journal:  Chemosphere       Date:  2020-10-24       Impact factor: 7.086

8.  Awareness, treatment, control, and determinants of dyslipidemia among adults in China.

Authors:  Sampson Opoku; Yong Gan; Emmanuel Addo Yobo; David Tenkorang-Twum; Wei Yue; Zhihong Wang; Zuxun Lu
Journal:  Sci Rep       Date:  2021-05-12       Impact factor: 4.379

Review 9.  Outcome Reporting Variability in Trials of Chinese Medicine for Hyperlipidemia: A Systematic Review for Developing a Core Outcome Set.

Authors:  Geng Li; Ruxue Han; Wencong Cao; Zehuai Wen; Xiankun Chen
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-10       Impact factor: 2.629

10.  Aberrant expression of HDL-bound microRNA induced by a high-fat diet in a pig model: implications in the pathogenesis of dyslipidaemia.

Authors:  Guoyuan Sui; Lianqun Jia; Nan Song; Dongyu Min; Si Chen; Yao Wu; Guanlin Yang
Journal:  BMC Cardiovasc Disord       Date:  2021-06-06       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.